semaglutide and heart disease in Cardiometabolic Diseases: SELECTing the Target Population Semaglutide breakthrough: new hope for

Centers for Medicare & Medicaid Services (2026) Medicaid coverage of and spending on GLP-1s, KFF (2026) Tirzepatide as compared with semaglutide for the treatment of obesity, The New England Journal of Medicine (2025) Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice

She also projected that 2026 will be defined by nutrition innovations across multiple categories, driven by consumers seeking products with tangible health benefits, ethical and environmental alignment, and convenient, science-backed solutions

Since stress can also be a big trigger for heart palpitations, taking time to destress, or engaging in practices like meditation and relaxation exercises, can help

they may also have direct effects in the brain (animal studies show neuroprotection and reduced amyloid/tau pathology)

The role of Akkermansia muciniphila in obesity, diabetes and atherosclerosis